Tempsens leads CY26 IPO debuts as Jio Platforms, NSE line up potential mega listings
Tempsens Instruments India debuted 93.57% above its ₹300 issue price, topping CY26 mainboard listing gains. With 53 IPOs listed so far, investors are watching a late-2026 pipeline that could include Reliance-linked Jio Platforms and the NSE, alongside large issues from SBI Funds Management and Manipal Health.
What happened
Jio Platforms · Tempsens led CY26 mainboard IPO listing gains with a 93.57% debut premium. Primary-market activity is accelerating ahead of anticipated mega
Key facts
- Tempsens IPO size: ₹650 crore
- Tempsens listing price: ₹580.70
- Tempsens offer price: ₹300
- Tempsens listing-day gain: 93.57%
- Tempsens free-float market capitalisation: ₹1,002.53 crore
- 53 mainboard IPOs listed in CY26TD
- Average listing gain: 10.86%
- 17 IPOs listed in August
- BSE IPO index YTD gain: 17%
- SBI Funds Management issue size: ₹9,813 crore
- Manipal Health Enterprises issue size: nearly ₹9,277 crore
- Clean Max Enviro Energy Solutions issue size: ₹3,087 crore
Why this matters
Corporate-development teams should monitor the late-2026 IPO calendar because mega deals could reshape valuation benchmarks, financing conditions and exit timing for retail-sector assets.
What to watch
- Official DRHP filings, SEBI observations or launch timelines for Jio Platforms, NSE, SBI Funds Management and Manipal Health.
- Changes in IPO subscription composition, especially declining QIB participation or rising dependence on HNI leverage.
- Grey-market premium trends and the median 30-day performance of newly listed mainboard IPOs.
- Domestic equity mutual-fund inflows, SIP contributions, margin-funding rates and broker IPO-financing activity.
- Nifty and mid-cap index volatility, FII flows, interest-rate expectations and any broad risk-off move.
- Number and value of IPOs scheduled within overlapping two-to-four-week windows in late 2026.
- Prioritize IPO participation by issuer quality, free-float scarcity, valuation versus listed peers and realistic post-listing liquidity rather than headline subscription levels.
- Reduce exposure to highly leveraged IPO-financing trades and short-duration strategies dependent on large listing pops.
- For retailers and consumer-facing companies considering public-market fundraising, accelerate audit readiness and investor education but retain flexibility on timing and valuation.
- Monitor whether domestic mutual funds and insurers are reserving capital for mega issues, which would signal tightening demand for smaller deals.
- Use potential mega-IPO demand as a benchmark for secondary-market rotation risk in recently listed mid-cap consumer, healthcare and technology names.